These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

874 related items for PubMed ID: 20470789

  • 1. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
    Sharma G, Mirza S, Parshad R, Srivastava A, Gupta SD, Pandya P, Ralhan R.
    Life Sci; 2010 Jul 17; 87(3-4):83-91. PubMed ID: 20470789
    [Abstract] [Full Text] [Related]

  • 2. Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
    Nakamichi I, Tomita Y, Zhang B, Sugiyama H, Kanakura Y, Fukuhara S, Hino M, Kanamaru A, Ogawa H, Aozasa K.
    Ann Hematol; 2007 Aug 17; 86(8):557-64. PubMed ID: 17508213
    [Abstract] [Full Text] [Related]

  • 3. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients.
    Mirza S, Sharma G, Prasad CP, Parshad R, Srivastava A, Gupta SD, Ralhan R.
    Life Sci; 2007 Jul 04; 81(4):280-7. PubMed ID: 17599361
    [Abstract] [Full Text] [Related]

  • 4. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma].
    Lou C, Yang B, Gao YT, Wang YJ, Nie FH, Yuan Q, Zhang CL, Du Z.
    Zhonghua Zhong Liu Za Zhi; 2008 Nov 04; 30(11):831-6. PubMed ID: 19173828
    [Abstract] [Full Text] [Related]

  • 5. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S, Hazra A, Tranah GJ, Kirkner GJ, Kawasaki T, Nosho K, Ohnishi M, Suemoto Y, Meyerhardt JA, Hunter DJ, Fuchs CS.
    Carcinogenesis; 2007 Sep 04; 28(9):1985-90. PubMed ID: 17621591
    [Abstract] [Full Text] [Related]

  • 6. Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas.
    Yachi K, Watanabe T, Ohta T, Fukushima T, Yoshino A, Ogino A, Katayama Y, Nagase H.
    Int J Oncol; 2008 Sep 04; 33(3):469-75. PubMed ID: 18695875
    [Abstract] [Full Text] [Related]

  • 7. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
    Asiaf A, Ahmad ST, Malik AA, Aziz SA, Rasool Z, Masood A, Zargar MA.
    Tumour Biol; 2015 Aug 04; 36(8):6485-96. PubMed ID: 25820821
    [Abstract] [Full Text] [Related]

  • 8. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E, Hillinck J, Ibanez de Caceres I, Al-Saleem T, Cairns P.
    Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [Abstract] [Full Text] [Related]

  • 9. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ.
    Hum Pathol; 2009 Nov 15; 40(11):1534-42. PubMed ID: 19695681
    [Abstract] [Full Text] [Related]

  • 10. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES, Issa JP, Roberts DB, Williams MD, Weber RS, Kies MS, El-Naggar AK.
    Clin Cancer Res; 2008 May 01; 14(9):2664-72. PubMed ID: 18451230
    [Abstract] [Full Text] [Related]

  • 11. Association of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation with p53 mutation occurrence in non-small cell lung cancer with different histology, gender, and smoking status.
    Wu JY, Wang J, Lai JC, Cheng YW, Yeh KT, Wu TC, Chen CY, Lee H.
    Ann Surg Oncol; 2008 Nov 01; 15(11):3272-7. PubMed ID: 18712569
    [Abstract] [Full Text] [Related]

  • 12. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
    Ahmed IA, Pusch CM, Hamed T, Rashad H, Idris A, El-Fadle AA, Blin N.
    Cancer Genet Cytogenet; 2010 Jun 01; 199(2):96-100. PubMed ID: 20471512
    [Abstract] [Full Text] [Related]

  • 13. Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer.
    Hoffmann AC, Kaifi JT, Vallböhmer D, Yekebas E, Grimminger P, Leers JM, Izbicki JR, Hölscher AH, Schneider PM, Metzger R, Brabender J.
    J Surg Oncol; 2009 Oct 01; 100(5):414-7. PubMed ID: 19653236
    [Abstract] [Full Text] [Related]

  • 14. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 01; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 15. Methylation of O6-methylguanine-DNA methyltransferase (MGMT) promoter gene in triple-negative breast cancer patients.
    Fumagalli C, Pruneri G, Possanzini P, Manzotti M, Barile M, Feroce I, Colleoni M, Bonanni B, Maisonneuve P, Radice P, Viale G, Barberis M.
    Breast Cancer Res Treat; 2012 Jul 01; 134(1):131-7. PubMed ID: 22228432
    [Abstract] [Full Text] [Related]

  • 16. Association between MGMT promoter hypermethylation and p53 mutation in glioblastoma.
    Shamsara J, Sharif S, Afsharnezhad S, Lotfi M, Raziee HR, Ghaffarzadegan K, Moradi A, Rahighi S, Behravan J.
    Cancer Invest; 2009 Oct 01; 27(8):825-9. PubMed ID: 19544111
    [Abstract] [Full Text] [Related]

  • 17. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB, Saboorian MH, Ashfaq R, Toyooka KO, Toyooka S, Minna JD, Gazdar AF, Schorge JO.
    Clin Cancer Res; 2005 Aug 01; 11(15):5365-9. PubMed ID: 16061849
    [Abstract] [Full Text] [Related]

  • 18. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L, Strzelczyk JK, Adamek B, Zalewska-Ziob M, Arendt J, Półtorak S, Maciejewski B, Wiczkowski A.
    Med Sci Monit; 2008 Oct 01; 14(10):BR219-25. PubMed ID: 18830187
    [Abstract] [Full Text] [Related]

  • 19. Promoter methylation of TIMP3 and CDH1 predicts better outcome in head and neck squamous cell carcinoma treated by radiotherapy only.
    De Schutter H, Geeraerts H, Verbeken E, Nuyts S.
    Oncol Rep; 2009 Feb 01; 21(2):507-13. PubMed ID: 19148529
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.